Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes

Metabolism: Clinical and Experimental

Volumn 64, Issue 12, 2015, Pages 1682-1693

  Liang, Yeyou ^a   Yuan, Weiwei ^b   Zhu, Wensi ^a   Zhu, Jiening ^b   Lin, Qiuxiong ^b   Zou, Xiao ^b   Deng, Chunyu ^b   Fu, Yongheng ^b   Zheng, Xilong ^c   Yang, Min ^b   Wu, Shulin ^b   Yu, Xiyong ^b   Shan, Zhixin ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiomyocyte; GLUT4; Macrophage migration inhibitory factor; MEF2; Zac1

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CD74 ANTIGEN; GLUCOSE TRANSPORTER 4; MACROPHAGE MIGRATION INHIBITION FACTOR; MEF2C PROTEIN; MEF2D PROTEIN; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZAC1 PROTEIN; B LYMPHOCYTE ANTIGEN; CELL CYCLE PROTEIN; HLA ANTIGEN CLASS 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR; INVARIANT CHAIN; ISOMERASE; MIF PROTEIN, MOUSE; PLAGL1 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GEL MOBILITY SHIFT ASSAY; GLUCOSE TRANSPORT; HEART MUSCLE CELL; INVESTIGATIVE PROCEDURES; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DIABETIC CARDIOMYOPATHY; GENETICS; HEART LEFT VENTRICLE FUNCTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL CYCLE PROTEINS; CELLS, CULTURED; DIABETIC CARDIOMYOPATHIES; GENES, TUMOR SUPPRESSOR; GLUCOSE TRANSPORTER TYPE 4; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; RECEPTOR, INSULIN; TRANSCRIPTION FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84947924615     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.09.007     Document Type: Article

References (69)

1. F.M. Ashcroft, and P. Rorsman Diabetes mellitus and the beta cell: the last ten years Cell 148 2012 1160 1171
2. B.R. Goyal, and A.A. Mehta Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfunction Hum Exp Toxicol 32 2013 571 590
3. I.G. Poornima, P. Parikh, and R.P. Shannon Diabetic cardiomyopathy: the search for a unifying hypothesis Circ Res 98 2006 596 605
4. J.K. Boyer, S. Thanigaraj, K.B. Schechtman, and J.E. Pérez Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus Am J Cardiol 93 2004 870 875
5. B.E. Suys, N. Katier, R.P. Rooman, D. Matthys, L. Op De Beeck, M.V. Du Caju, and et al. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy Diabetes Care 27 2004 1947 1953
6. A. Aneja, W.H. Tang, S. Bansilal, M.J. Garcia, and M.E. Farkouh Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options Am J Med 121 2008 748 757
7. R. Tarquini, C. Lazzeri, L. Pala, C.M. Rotella, and G.F. Gensini The diabetic cardiomyopathy Acta Diabetol 48 2011 173 181
8. X. Palomer, L. Salvadó, E. Barroso, and M. Vázquez-Carrera An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy Int J Cardiol 168 2013 3160 3172
9. Z.Y. Fang, J.B. Prins, and T.H. Marwick Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 2004 543 567
10. E.J. Miller, J. Li, L. Leng, C. McDonald, T. Atsumi, R. Bucala, and et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart Nature 451 2008 578 582
11. X.Y. Yu, H.M. Chen, J.L. Liang, Q.X. Lin, H.H. Tan, Y.H. Fu, and et al. Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor PLoS One 6 2011 e16239
12. N. Yabunaka, J. Nishihira, Y. Mizue, M. Tsuji, M. Kumagai, Y. Ohtsuka, and et al. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes Diabetes Care 23 2000 256 258
13. C. Herder, H. Kolb, W. Koenig, B. Haastert, S. Müller-Scholze, W. Rathmann, and et al. Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4) Diabetes Care 29 2006 368 371
14. C. Herder, N. Klopp, J. Baumert, M. Müller, N. Khuseyinova, C. Meisinger, and et al. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002 Diabetologia 51 2008 276 284
15. T.S. Church, M.S. Willis, E.L. Priest, M.J. Lamonte, C.P. Earnest, W.J. Wilkinson, and et al. Obesity, macrophage migration inhibitory factor, and weight loss Int J Obes (Lond) 29 2005 675 681
16. P. Dandona, A. Aljada, H. Ghanim, P. Mohanty, C. Tripathy, D. Hofmeyer, and et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin J Clin Endocrinol Metab 89 2004 5043 5047
17. C. Tong, A. Morrison, X. Yan, P. Zhao, E.D. Yeung, J. Wang, and et al. Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in type 1 diabetic murine cardiomyocytes J Diabetes 2 2010 267 274
18. D. Qi, X. Hu, X. Wu, M. Merk, L. Leng, R. Bucala, and et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion J Clin Invest 119 2009 3807 3816
19. H. Ma, J. Wang, D.P. Thomas, C. Tong, L. Leng, W. Wang, and et al. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart Circulation 122 2010 282 292
20. K. Koga, A. Kenessey, and K. Ojamaa Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy Am J Physiol Heart Circ Physiol 304 2012 H282 H293
21. X. Xu, Y. Hua, S. Nair, R. Bucala, and J. Ren Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy Hypertension 63 2014 490 499
22. X. Xu, B.D. Pacheco, L. Leng, R. Bucala, and J. Ren Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy Cardiovasc Res 99 2013 412 421
23. E.D. Abel, H.C. Kaulbach, R. Tian, J.C. Hopkins, J. Duffy, T. Doetschman, and et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart J Clin Invest 104 1999 1703 1714
24. M.R. Laughlin, J.F. Taylor, A.S. Chesnick, and R.S. Balaban Regulation of glycogen metabolism in canine myocardium: effects of insulin and epinephrine in vivo Am J Physiol 262 1992 E875 E883
25. K.E. Flaim, P.J. Kochel, Y. Kira, K. Kobayashi, E.T. Fossel, L.S. Jefferson, and et al. Insulin effects on protein synthesis are independent of glucose and energy metabolism Am J Physiol 245 1983 C133 C143
26. C. Depre, M.H. Rider, and L. Hue Mechanisms of control of heart glycolysis Eur J Biochem 258 1998 277 290
27. R. Aikawa, M. Nawano, Y. Gu, H. Katagiri, T. Asano, W. Zhu, and et al. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt Circulation 102 2000 2873 2879
28. J. Ren, J.R. Sowers, M.F. Walsh, and R.A. Brown (2000) Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats Am J Physiol Heart Circ Physiol 279 2000 H1708 H1714
29. B. Rodrigues, M.C. Cam, and J.H. McNeill Metabolic disturbances in diabetic cardiomyopathy Mol Cell Biochem 180 1998 53 57
30. E.D. Abel Myocardial insulin resistance and cardiac complications of diabetes Curr Drug Targets Immune Endocr Metabol Disord 5 2005 219 226
31. D.M. Ouwens, and M. Diamant Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy Arch Physiol Biochem 113 2007 76 86
32. B.B. Kahn Lilly lecture 1995. Glucose transport: pivotal step in insulin action Diabetes 45 1996 1644 1654
33. A.L. Olson, and J.E. Pessin Structure, function, and regulation of Mammalian facilitative glucose transporter gene family Ann Rev Nutr 16 1996 235 256
34. W.T. Garvey, L. Maianu, J.H. Zhu, G. Brechtel-Hook, P. Wallace, and A.D. Baron Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance J Clin Invest 101 1998 2377 2386
35. J.J. Wright, J. Kim, J. Buchanan, S. Boudina, S. Sena, K. Bakirtzi, and et al. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding Cardiovasc Res 82 2009 351 360
36. Z. Guo, Z. Xia, V.G. Yuen, and J.H. McNeill Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats Metabolism 56 2007 1363 1371
37. D.D. Belke, T.S. Larsen, E.M. Gibbs, and D.L. Severson Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter Am J Physiol Endocrinol Metab 280 2001 E420 E427
38. J.N. Zhu, R. Chen, Y.H. Fu, Q.X. Lin, S. Huang, L.L. Guo, and et al. Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat PLoS One 8 2013 e75557
39. C. Communal, K. Singh, D. Pimentel, and W.S. Colucci Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway Circulation 98 1998 1329 1334
40. A.L. Olson, and J.E. Pessin Transcriptional regulation of the human GLUT4 gene promoter in diabetic transgenic mice J Biol Chem 270 1995 23491 23495
41. T. Kolter, I. Uphues, and J. Eckel Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats Am J Physiol 273 1997 E59 E67
42. H. Li, X. Wang, Y. Mao, R. Hu, W. Xu, Z. Lei, and et al. Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK Cardiovasc Diabetol 13 2014 24
43. J. Wang, C. Tong, X. Yan, E. Yeung, S. Gandavadi, A.A. Hare, and et al. Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction Circulation 128 2013 225 236
44. B.F. Holmes, E.J. Kurth-Kraczek, and W.W. Winder Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle J Appl Physiol 87 1999 1990 1995
45. L.G. Fryer, F. Foufelle, K. Barnes, S.A. Baldwin, A. Woods, and D. Carling Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells Biochem J 363 2002 167 174
46. R.R. Russell III, J. Li, D.L. Coven, M. Pypaert, C. Zechner, M. Palmeri, and et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
47. X. Xu, and J. Ren Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity Int J Obes (Lond) 39 2015 387 396
48. L. Chen, F. Wang, X. Sun, J. Zhou, L. Gao, Y. Jiao, and et al. Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium Exp Mol Med 42 2010 205 215
49. C.X. Yao, C.J. Xiong, W.P. Wang, F. Yang, S.F. Zhang, T.Q. Wang, and et al. Transcription factor GATA-6 recruits PPARα to cooperatively activate Glut4 gene expression J Mol Biol 415 2012 143 158
50. S. Gray, M.W. Feinberg, S. Hull, C.T. Kuo, M. Watanabe, S. Sen-Banerjee, and et al. The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4 J Biol Chem 277 2002 34322 34328
51. A. Zorzano, M. Palacín, and A. Gumà Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle Acta Physiol Scand 183 2005 43 58
52. R. Marín-Juez, M. Diaz, J. Morata, and J.V. Planas Mechanisms regulating GLUT4 transcription in skeletal muscle cells are highly conserved across vertebrates PLoS One 8 2013 e80628
53. S. Mora, and J.E. Pessin The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter J Biol Chem 275 2000 16323 16328
54. M.P. Czubryt, L. Lamoureux, A. Ramjiawan, B. Abrenica, J. Jangamreddy, and K. Swan Regulation of cardiomyocyte Glut4 expression by ZAC1 J Biol Chem 285 2010 16942 16950
55. S. Miura, Y. Kai, M. Ono, and O. Ezaki Overexpression of peroxisome proliferator-activated receptor gamma coactivator-1alpha down-regulates GLUT4 mRNA in skeletal muscles J Biol Chem 278 2003 31385 31390
56. T. Horie, K. Ono, H. Nishi, Y. Iwanaga, K. Nagao, M. Kinoshita, and et al. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes Biochem Biophys Res Commun 389 2009 315 320
57. H. Lu, R.J. Buchan, and S.A. Cook MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism Cardiovasc Res 86 2010 410 420
58. S. Chen, J. Murphy, R. Toth, D.G. Campbell, N.A. Morrice, and C. Mackintosh Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators Biochem J 409 2008 449 459
59. S. Jäger, C. Handschin, J. St-Pierre, and B.M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α Proc Natl Acad Sci U S A 104 2007 12017 12022
60. C. Cantó, L.Q. Jiang, A.S. Deshmukh, C. Mataki, A. Coste, M. Lagouge, and et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle Cell Metab 11 2010 213 219
61. Y. Li, S. Xu, M.M. Mihaylova, B. Zheng, X. Hou, B. Jiang, and et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab 13 2011 376 388
62. R. Kjøbsted, J.T. Treebak, J. Fentz, L. Lantier, B. Viollet, J.B. Birk, and et al. Prior AICAR stimulation increases insulin sensitivity in mouse skeletal muscle in an AMPK-dependent manner Diabetes 64 2015 2042 2055
63. X.J. Xu, R.J. Valentine, and N.B. Ruderman AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity? Curr Obes Rep 3 2 2014 248 255
64. Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ikeda, and et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc Res 61 2004 610 619
65. E.F. Morand, M. Leech, and J. Bernhagen MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis Nat Rev Drug Discov 5 2006 399 410
66. T. Calandra, and T. Roger Macrophage migration inhibitory factor: a regulator of innate immunity Nat Rev Immunol 3 2003 791 800
67. J. Bernhagen, R. Krohn, H. Lue, J.L. Gregory, A. Zernecke, R.R. Koenen, and et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment Nat Med 13 2007 587 596
68. L. Leng, C.N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, and et al. MIF signal transduction initiated by binding to CD74 J Exp Med 197 2003 1467 1476
69. D. Heinrichs, M. Knauel, C. Offermanns, M.L. Berres, A. Nellen, L. Leng, and et al. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74 Proc Natl Acad Sci U S A 108 2011 17444 17449